Embargoed until 31st August 2024
Novel low-dose 3-in-1 blood pressure pill significantly outperforms standard care, study shows Over 80% of patients achieved control within a month, sustained at six months New research shows that a treatment plan based on novel combination of low doses of three anti-hypertensive drugs in a single pill – known as GMRx2 – was superior to…